Cargando…
Immunotherapy for human papillomavirus-associated disease and cervical cancer: review of clinical and translational research
Cervical cancer is the fourth most lethal women's cancer worldwide. Current treatments against cervical cancer include surgery, radiotherapy, chemotherapy, and anti-angiogenic agents. However, despite the various treatments utilized for the treatment of cervical cancer, its disease burden remai...
Autores principales: | Lee, Sung-Jong, Yang, Andrew, Wu, T.-C., Hung, Chien-Fu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4944018/ https://www.ncbi.nlm.nih.gov/pubmed/27329199 http://dx.doi.org/10.3802/jgo.2016.27.e51 |
Ejemplares similares
-
Human Papillomavirus T-Cell Cross-reactivity in Cervical Cancer: Implications for Immunotherapy Clinical Trial Design
por: Helman, Sarah R., et al.
Publicado: (2018) -
Translational Models in Glioma Immunotherapy Research
por: Ren, Alexander L., et al.
Publicado: (2023) -
High-risk Human Papillomavirus Infection in Low Risk Women: Incidence, Patient Characteristics, and Clinical Meaning for Cervical Cancer
por: Lee, Sung Jong, et al.
Publicado: (2011) -
Human papillomavirus genotype-specific risk in cervical carcinogenesis
por: So, Kyeong A, et al.
Publicado: (2019) -
Human Papillomavirus and Cervical Cancer
por: Unger, Elizabeth R., et al.
Publicado: (2004)